Literature DB >> 22364557

Nonparametric inference for median costs with censored data.

Hongwei Zhao1, Chen Zuo, Shuai Chen, Heejung Bang.   

Abstract

Increasingly, estimations of health care costs are used to evaluate competing treatments or to assess the expected expenditures associated with certain diseases. In health policy and economics, the primary focus of these estimations has been on the mean cost, because the total cost can be derived directly from the mean cost, and because information about total resources utilized is highly relevant for policymakers. Yet, the median cost also could be important, both as an intuitive measure of central tendency in cost distribution and as a subject of interest to payers and consumers. In many prospective studies, cost data collection is sometimes incomplete for some subjects due to right censoring, which typically is caused by loss to follow-up or by limited study duration. Censoring poses a unique challenge for cost data analysis because of so-called induced informative censoring, in that traditional methods suited for survival data generally are invalid in censored cost estimation. In this article, we propose methods for estimating the median cost and its confidence interval (CI) when data are subject to right censoring. We also consider the estimation of the ratio and difference of two median costs and their CIs. These methods can be extended to the estimation of other quantiles and other informatively censored data. We conduct simulation and real data analysis in order to examine the performance of the proposed methods.
© 2012, The International Biometric Society.

Entities:  

Mesh:

Year:  2012        PMID: 22364557      PMCID: PMC3880200          DOI: 10.1111/j.1541-0420.2012.01755.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  16 in total

1.  Median regression with censored cost data.

Authors:  Heejung Bang; Anastasios A Tsiatis
Journal:  Biometrics       Date:  2002-09       Impact factor: 2.571

2.  On estimators of medical costs with censored data.

Authors:  Anthony O'Hagan; John W Stevens
Journal:  J Health Econ       Date:  2004-05       Impact factor: 3.883

3.  Estimating medical care costs under conditions of censoring.

Authors:  M Raikou; A McGuire
Journal:  J Health Econ       Date:  2004-05       Impact factor: 3.883

4.  Estimating mean cost using auxiliary covariates.

Authors:  Wenqin Pan; Donglin Zeng
Journal:  Biometrics       Date:  2011-01-06       Impact factor: 2.571

5.  Estimating medical costs from incomplete follow-up data.

Authors:  D Y Lin; E J Feuer; R Etzioni; Y Wax
Journal:  Biometrics       Date:  1997-06       Impact factor: 2.571

6.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

7.  Nonparametric estimation for the difference or ratio of median failure times.

Authors:  J Q Su; L J Wei
Journal:  Biometrics       Date:  1993-06       Impact factor: 2.571

8.  Surgical and transcatheter (Amplatzer) closure of atrial septal defects: a prospective comparison of results and cost.

Authors:  J D R Thomson; E H Aburawi; K G Watterson; C Van Doorn; J L Gibbs
Journal:  Heart       Date:  2002-05       Impact factor: 5.994

9.  Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials.

Authors:  Deborah A Taira; Todd B Seto; Richard Siegrist; Roberta Cosgrove; Ronna Berezin; David J Cohen
Journal:  Am Heart J       Date:  2003-03       Impact factor: 4.749

10.  Cost analysis with censored data.

Authors:  Yijian Huang
Journal:  Med Care       Date:  2009-07       Impact factor: 2.983

View more
  7 in total

1.  Generalized Redistribute-to-the-Right Algorithm: Application to the Analysis of Censored Cost Data.

Authors:  Shuai Chen; Hongwei Zhao
Journal:  J Stat Theory Pract       Date:  2013-04-01

2.  Estimating incremental cost-effectiveness ratios and their confidence intervals with different terminating events for survival time and costs.

Authors:  Shuai Chen; Hongwei Zhao
Journal:  Biostatistics       Date:  2013-02-19       Impact factor: 5.899

3.  Cost-effectiveness analysis: a proposal of new reporting standards in statistical analysis.

Authors:  Heejung Bang; Hongwei Zhao
Journal:  J Biopharm Stat       Date:  2014       Impact factor: 1.051

4.  Semiparametric Estimation of Longitudinal Medical Cost Trajectory.

Authors:  Liang Li; Chih-Hsien Wu; Jing Ning; Xuelin Huang; Ya-Chen Tina Shih; Yu Shen
Journal:  J Am Stat Assoc       Date:  2018-06-18       Impact factor: 5.033

5.  Median-based incremental cost-effectiveness ratios with censored data.

Authors:  Heejung Bang; Hongwei Zhao
Journal:  J Biopharm Stat       Date:  2015-05-26       Impact factor: 1.051

6.  The cost of diagnosing endometrial cancer: Quantifying the healthcare cost of an abnormal uterine bleeding workup.

Authors:  Simrit K Warring; Bijan Borah; James Moriarty; Rachel Gullerud; Maureen A Lemens; Christopher Destephano; Mark E Sherman; Jamie N Bakkum-Gamez
Journal:  Gynecol Oncol       Date:  2021-10-28       Impact factor: 5.482

7.  Median-Based Incremental Cost-Effectiveness Ratio (ICER).

Authors:  Heejung Bang; Hongwei Zhao
Journal:  J Stat Theory Pract       Date:  2012-08-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.